Cardiff Lexington signs LOI to acquire musculoskeletal platform for up to $104M

Cardiff Lexington Corp

LOI with owners of multi-location musculoskeletal platform; total purchase price up to $104 million.
Consideration: $30M cash at close, $10M notes due 2 years, preferred equity = 35% fully diluted, plus $12M stock earnout.
Earnout: $4M stock each if 2027 EBITDA >$15M, 2028 >$18M, 2029 >$22M.
Due diligence up to 45 days; target closing date November 16, 2026; financing not yet committed.
Proposed deal expands orthopedics, spine, pain management; sellers to retain leadership roles.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.